Amiodarone and optic neuropathy

Acta Ophthalmologica Scandinavica

Volumn 82, Issue 3 I, 2004, Pages 277-282

  Domingues, M F ^a   Barros, H ^a   Falcao Reis F M ^a  

^a University of Porto   (Portugal)

Author keywords

Amiodarone; Cardiology; Computerized contrast sensitivity; Optic neuropathy; Pattern visual evoked potentials; Visual fields

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; TROPICAMIDE; WARFARIN;

ACTION POTENTIAL; ADULT; AGED; AMBLYOPIA; ARTICLE; AUTOMATION; CATARACT; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; CORNEA DISEASE; CORRELATION FUNCTION; DATA ANALYSIS; DIABETES MELLITUS; EVOKED VISUAL RESPONSE; EYE DISEASE; EYE FUNDUS; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; KERATOPATHY; KINETICS; LATENT PERIOD; LONG TERM CARE; MALE; OPTIC DISK; OPTIC NERVE DISEASE; OUTCOMES RESEARCH; PERIMETRY; PRIORITY JOURNAL; SCREENING TEST; STANDARD; STATISTICAL SIGNIFICANCE; VISION TEST; VISUAL ACUITY; VISUAL FIELD; VISUAL FIELD DEFECT; VISUAL SYSTEM EXAMINATION; VISUAL SYSTEM PARAMETERS;

EID: 2642549268     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2004.00255.x     Document Type: Article

References (50)

1. Baritussio A, Marzini S, Agostini M et al. (2001): Amiodarone inhibits lung degradation of SP-A and perturbs the distribution of lysosomal enzymes. Am J Physiol Lung Cell Mol Physiol 281: 1189-1199.
2. Bartolucci J, Ibanez P, Verdugo C, Fuentes R, Arriagada G & Torres J (1999): Neuritis retrobulbar inducida per amiodarona. Caso clínico. Rev Med Chil 127: 827-830.
3. Belec L, Davila G, Bleibel JM, Azoulay A, Laloun L & Poisson M (1992): Neuropathie optique bilaterale an cours d'untraitemant prolonge par l'amiodarone. Ann Med Interne Paris 143: 349-350.
4. Besser R, Treese N, Bohl J & Goebel HH (1994): Klinische, neurophysiologische und bioptische Befunde beim neurotoxischen Amiodaronsyndrom. Med Klin 89: 367-372.
5. Bockhardt H, Drenckhahn D & Lullmann-Rauch R (1978): Amiodarone-induced lipidosis-like alterations in ocular tissues of rats. Graefes Arch Clin Exp Ophthalmol 17: 91-96.
6. Bolt MW, Card JW, Racz WJ, Brien JF & Massey TE (2001): Disruption of mitochondrial function and cellular ATP levels by amiodarone and N-desethylamiodarone in initiation of amiodarone-induced pulmonary cytotoxicity. J Pharmacol Exp Ther 298: 1280-1289.
7. Burns KE, Piliotis E, Garcia BM & Ferguson KA (2000): Amiodarone pulmonary, neuromuscular and ophthalmological toxicity. Can Respir J 7: 193-197.
8. Dake MD, Madison JM, Montgomery CK, Shellito JE, Hinchcliffe WA, Winkler ML & Bainton DF (1985): Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes and blood leucocytes of patients with amiodarone pulmonary toxicity. Am J Med 78: 506-512.
9. Dewachter A & Lievens H (1988): Amiodarone and optic neuropathy. II. Soc Belge Ophtalmol 227: 47-50.
10. Duff GR & Fraser AG (1987): Impairment of colour vision associated with amiodarone keratopathy. Acta Ophthalmol (Copenh) 65: 48-52.
11. Endoh Y, Hanai R, Uto K, Tanaka T, Ohta Y, Kasanuki H & Ohnishi S (2000): Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity. Pacing Clin Electrophysiol 23: 2010-2013.
12. Eryilmaz T, Atilla H, Batioglu F & Gunalp I (2000): Amiodarone-related optic neuropathy. Jpn J Ophthalmol 44: 565-568.
13. Falcão-Reis FM, O'Sullivan F, Spileers W, Hogg C & Arden GB (1991): Macular colour contrast sensitivity in ocular hypertension and glaucoma: evidence for two types of defect. Br J Ophthalmol 75: 598-602.
14. Feiner LA, Yonge BR, Kazmier FJ, Stricker BH & Fraunfelder FT (1987): Optic neuropathy and amiodarone therapy. Mayo Clin Proc 62: 702.
15. Ferreiro JL, Isern-Longares JA & Ramon-Moya AF (1990): Neuropatia optica por amiodarona. Neurologia 5: 160-163.
16. Fraunfelder FT & Fraunfelder FW (2001): Cardiac, vascular and renal agents. In: Randall JA (ed). Drug-Induced Ocular Side Effects. Boston: Butterworth-Heinemann 273-278.
17. Garrett SN, Kearney JJ & Schiffman JS (1988): Amiodarone optic neuropathy. J Clin Neuroophthalmol 8: 105-110.
18. Ghosh M & McCulloch C (1984): Amiodarone-induced ultrastructural changes in human eyes. Can J Ophthalmol 19: 178-186.
19. Gittinger JW & Asdourian GK (1987): Papillopathy caused by amiodarone. Arch Ophthalmol 105: 349.
20. Gobbele R, Dahlke C, Mull M & Schwarz M (1999): Amiodaron-induzierte bilaterale Optikusneuropathie: eine Kasuistik. Nerve-narzt 70: 560-565.
21. Halliday AM (1982): Evoked Potentials in Clinical Testing. Edinburgh: Churchill Livingstone Inc.
22. Harding GFA, Odom JV, Spileers W & Spekreijse H (1996): Standard for visual evoked potentials. Vision Res 36: 3567-3572.
23. Hasan T, Kochevar IE & Abdulah D (1984): Amiodarone phototoxicity to human erythrocytes and lymphocytes. Photochem Photobiol 40: 715-719.
24. Ikäheimo K, Kettunen R & Mäntyjärvi M (2002): Visual functions and adverse ocular effects in patients with amiodarone medication. Acta Ophthalmol Scand 80: 59-63.
25. Ingram DV, Jaggarao NSV & Chamberlain DA (1982): Ocular changes resulting from therapy with amiodarone. Br J Ophthalmol 66: 676-679.
26. Jacobs JM & Costa-Jussa FR (1985): The pathology of amiodarone neurotoxicity. II. Peripheral neuropathy in man. Brain 108: 753-769.
27. Krieg P & Schipper I (1992): Bilaterale Optikoneuropathie nach Amiodarontherapie. Klin Monatsbl Augenheilkd 200: 128-132.
28. Leifert D, Hansen LL & Gerling J (2000): Amiodaron-Optikusneuropathie: ein eigenständiges Krankheitsbild? Klin Monatsbl Augenheilkd 217: 171-177.
29. Macaluso DC, Shults WT & Fraunfelder FT (1999): Features of amiodarone optic neuropathy. Am J Ophthalmol 127: 610-613.
30. Mansour AM, Puklin JE & O'Grady R (1988): Optic nerve ultrastructure following amiodarone therapy. J Clin Neuroophthalmol 8: 231-237.
31. Mäntyjärvi M, Tuppurainen K & Ikäheimo K (1998): Ocular side-effects of amiodarone. Surv Ophthalmol 42: 360-366.
32. Masson C, Boulu P & Henin D (1992): Les neuropathies iatrogenes. Rev Med Interne 13: 225-232.
33. Mindel JM (1998): Amiodarone and optic neuropathy - a medicolegal issue. [Editorial.] Surv Ophthalmol 42: 358-359.
34. Naccarelli GV, Rinkenberger RL, Dougherty AH & Giebel RA (1985): Amiodarone: pharmacology and antiarrhythmic and adverse effects. Pharmacotherapy 5: 298-313.
35. Nazarian SM & Jay WM (1988): Bilateral optic neuropathy associated with amiodarone therapy. J Clin Neuroophthalmol 8: 25-28.
36. Nicholson AA, Caplin JL & Steventon DM (1994): Measurement of tissue-bound amiodarone and its metabolites by computed tomography. Clin Radiol 49: 14-18.
37. Palimar P & Cota N (1998): Bilateral anterior ischaemic optic neuropathy following amiodarone. Eye 12: 894-896.
38. Polak BC, Tutein Nolthenius PA & Rietveld E (2001): Slechtziendheid door iatrogene opticusneuropatie. Ned Tijdschr Geneeskd 12: 922-926.
39. Roden DM (1996): Anti-arrhythmic drugs. In: Hardman JG, Limbird LE, Molinoff PB, Goodman LS, Rudon RW & Gilman AG (eds). Goodman and Gilman's: The Pharmacological Basis of Therapeutics. New York: McGraw Hill 858-862.
40. Santoro L, Barbieri F, Nucciotti R, Battaglia F, Crispi F, Ragno M, Greco P & Caruso G (1992): Amiodarone-induced experimental acute neuropathy in rats. Muscle Nerve 15: 788-795.
41. Schneck ME & Haegerstrom-Portnoy G (1997): Colour vision defect type and spatial vision in the optic neuritis treatment trial. Invest Ophthalmol Vis Sci 38: 2278-2289.
42. Sedwick LA (1992): Getting to the heart of visual loss: when cardiac medication may be dangerous to the optic nerves. [Clinical conference.] Surv Ophthalmol 36: 366-372.
43. Seemongal-Dass RR & Spencer SR (1998): Bilateral optic neuropathy linked with amiodarone. [Letter.] Eye 12: 474-477.
44. Sobieszczanska M, Pilecki W, Borodulin-Nadzieja L, Kalka D, Janocha A & Salomon E (1998): Wplyw plci badanych osob na przebieg wzrokowych potencjalow wywolanych wzorem szachownicy. Klin Oczna 100: 269-273.
45. Spaniol M, Bracher R, Ha HR, Follath F & Krahenbuhl S (2001): Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria. J Hepatol 35: 628-636.
46. Speicher MA, Goldman MH & Chrousos GA (2000): Amiodarone optic neuropathy without disc oedema. J Neuroophthalmol 20: 171-172.
47. Sreih AG, Schoenfeld MH & Marieb MA (1999): Optic neuropathy following amiodarone therapy. Pacing Clin Electrophysiol 22: 1108-1110.
48. Uebermuth CA & Gerke E (2002): Zunächst einseitige, später beidseitige Optikopathie Amiodaron als Ursache? Ophthalmologe 99: 470-473.
49. Vorperian VR, Havighurst TC, Miller S & January CT (1997): Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 30: 799-801.
50. Watillon M, Lavergne G & Weekers JF (1968): Corneal lesions during treatment with cordarone (amiodarone hydrochloride). Bull Soc Belge Ophthalmol 150: 715-726.